Entellus Medical to Report First Quarter 2017 Financial Results on May 3, 2017
April 19 2017 - 7:00PM
Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company
focused on delivering superior patient and physician experiences
through products designed for the minimally invasive treatment of
chronic and recurrent sinusitis patients, as well as the treatment
of patients with Eustachian tube dysfunction, today announced that
it will release its financial results for the first quarter 2017
after the close of trading on Wednesday, May 3, 2017. The Company’s
management team will host a corresponding conference call beginning
at 3:30pm CT/4:30pm ET to discuss the financial results and recent
business developments.
Individuals interested in listening to the conference call may
do so by dialing (877) 930-5751 for domestic callers or (253)
336-7277 for international callers, using Conference ID: 97479321.
To listen to a live webcast, please visit the investor relations
section of the Entellus Medical website at:
www.entellusmedical.com.
The webcast replay will be available on the Entellus Medical
website following the completion of the call.
About Entellus Medical, Inc.
Entellus Medical is a medical technology company focused on
delivering superior patient and physician experiences through
products designed for the minimally invasive treatment of
patients. Entellus products are used for the treatment of
adult and pediatric patients with chronic and recurrent sinusitis,
as well as adult patients with persistent Eustachian tube
dysfunction. The Entellus Medical platform of products
provides effective and easy-to-use solutions intended to help
simplify everything from diagnosis and patient selection, to
complex case revisions and post-operative care. Entellus Medical’s
core product lines, XprESS™ ENT Dilation System, MiniFESS™ Surgical
Instruments, XeroGel Nasal Dressing and FocESS™ Imaging &
Navigation, combine to enable ENT physicians to conveniently and
comfortably perform a broad range of procedures in the office and
simplify treatment based in the operating room. Entellus Medical is
committed to broadening its product portfolio with high-quality and
purposeful innovations for the global ENT market.
Contact: Lynn Pieper Lewis
415-937-5402
ir@entellusmedical.com
ENTELLUS MEDICAL INC (NASDAQ:ENTL)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENTELLUS MEDICAL INC (NASDAQ:ENTL)
Historical Stock Chart
From Jul 2023 to Jul 2024